Biocon Limited has informed the Exchange regarding a press release dated December 02, 2025, titled "Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in Europe and Rest of the World®".
Biocon Limited has informed the Exchange regarding a press release dated December 02, 2025, titled "Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in Europe and Rest of the World®".